Does TAFASITAMAB-CXIX Cause Off label use? 126 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Off label use have been filed in association with TAFASITAMAB-CXIX. This represents 17.1% of all adverse event reports for TAFASITAMAB-CXIX.
126
Reports of Off label use with TAFASITAMAB-CXIX
17.1%
of all TAFASITAMAB-CXIX reports
7
Deaths
20
Hospitalizations
How Dangerous Is Off label use From TAFASITAMAB-CXIX?
Of the 126 reports, 7 (5.6%) resulted in death, 20 (15.9%) required hospitalization, and 3 (2.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB-CXIX. However, 126 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB-CXIX Cause?
Disease progression (218)
Lymphoma (158)
Death (53)
Drug ineffective (39)
Blood lactate dehydrogenase increased (34)
Diffuse large b-cell lymphoma (32)
Malignant neoplasm progression (30)
Neutropenia (30)
Polyneuropathy (29)
Covid-19 (28)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TAFASITAMAB-CXIX Alternatives Have Lower Off label use Risk?
TAFASITAMAB-CXIX vs TAFINLAR
TAFASITAMAB-CXIX vs TAFLUPROST
TAFASITAMAB-CXIX vs TAGRAXOFUSP-ERZS
TAFASITAMAB-CXIX vs TAHOR
TAFASITAMAB-CXIX vs TALAZOPARIB